Nocutil (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Nocutil, is a vasopressin (antidiuretic hormone) analog presented as an oral formulation for oral use. It treats central diabetes insipidus, nocturnal polyuria, primary nocturnal enuresis, hemophilia A and von Willebrand disease in appropriate patients.

GNH USA supplies Nocutil as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acetate is used to manage disorders related to water balance and coagulation factor deficiency.

Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption. Nocturnal polyuria: decreases nighttime urine volume, improving sleep continuity. Primary nocturnal enuresis: lowers bedwetting episodes in children. Hemophilia A: raises plasma factor VIII levels to aid clot formation. von Willebrand disease: elevates von Willebrand factor to improve platelet adhesion.

Desmopressin acetate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional stomach upset. - Hyponatremia: mild electrolyte disturbance. - Flushing: transient skin reddening.

Serious or Rare Side Effects: - Severe hyponatremia with seizures: potentially life‑threatening. - Thromboembolic events: rare clot formation. - Allergic reaction: rash, itching, or anaphylaxis.

When prescribing desmopressin acetate, clinicians should observe several safety measures.

Assess fluid balance: monitor urine output and body weight. Check serum sodium: avoid rapid correction and hyponatremia. Use caution in renal impairment: adjust monitoring. Avoid concomitant use with other antidiuretic agents: increase risk of water retention. Pregnancy and lactation: safety not established; weigh benefits vs risks. Store at below 25°C: keep in original packaging, protect from moisture and light.

Desmopressin acetate interacts with several drug classes; awareness helps prevent complications.

Major Interactions (Avoid): - Carbamazepine or other CYP450 inducers: may reduce desmopressin efficacy. - Other antidiuretic agents (e.g., chlorpropamide, thiazide diuretics): risk of severe hyponatremia. - NSAIDs that impair renal prostaglandin synthesis: may potentiate water retention.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): increased factor VIII may affect clotting tests. - SSRIs or SNRIs: additive effect on serotonin may increase hyponatremia risk. - Alcohol: can exacerbate hyponatremia.